EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,000 | -20.0% | 1,100 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $25,000 | +13.6% | 1,100 | 0.0% | 0.01% | +7.7% |
| Q4 2020 | $22,000 | -18.5% | 1,100 | 0.0% | 0.01% | -23.5% |
| Q3 2020 | $27,000 | +3.8% | 1,100 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $26,000 | +85.7% | 1,100 | +37.5% | 0.02% | +54.5% |
| Q1 2020 | $14,000 | 0.0% | 800 | 0.0% | 0.01% | +22.2% |
| Q4 2019 | $14,000 | +27.3% | 800 | +33.3% | 0.01% | +28.6% |
| Q3 2019 | $11,000 | -42.1% | 600 | -33.3% | 0.01% | -46.2% |
| Q2 2019 | $19,000 | -9.5% | 900 | 0.0% | 0.01% | -13.3% |
| Q1 2019 | $21,000 | -8.7% | 900 | -30.8% | 0.02% | -6.2% |
| Q3 2018 | $23,000 | -17.9% | 1,300 | 0.0% | 0.02% | -23.8% |
| Q2 2018 | $28,000 | -3.4% | 1,300 | 0.0% | 0.02% | +5.0% |
| Q1 2018 | $29,000 | -75.2% | 1,300 | -66.2% | 0.02% | -73.7% |
| Q4 2017 | $117,000 | -2.5% | 3,850 | -22.2% | 0.08% | -6.2% |
| Q3 2017 | $120,000 | – | 4,950 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |